Key result
Updated JCS/JHRS guideline details evidence-based pharmacotherapy and management strategies for cardiac arrhythmias.
Answers are grounded in this paper and cite their sources.
Standardizes arrhythmia care in Japan; leaves open validation against post-2020 trials and non-Japanese populations.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Hideki Itoh (2022) conducted a review in Cardiac Arrhythmias. Antiarrhythmic drugs was evaluated. The JCS/JHRS 2020 Guideline provides comprehensive, evidence-based recommendations on the mechanisms, diagnosis, and pharmacological treatment of cardiac arrhythmias.
Synapse has enriched 10 related papers. Consider them for comparative context: